Opinion: Health Booth 2020

Using a SMART card containing your genetic information and medical history, you could one day soon be diagnosed and treated for all kinds of diseases at an ATM-style kiosk.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

WIKIMEDIA, WALTER BAXTERFrance was the first country to use plastic-embedded simultaneous multiple algorithm technology (SMART) back in early 1970s. We then witnessed a global explosion of these data-holding cards for banking and other applications during the following decades. Now, at the start of this century, we are pushing this technology into health care by beginning to develop a health SMART (H-SMART) card that has the potential to transform health care delivery into a more efficient, precise, economic, and readily accessible system than ever before imaginable.

The development of the H-SMART card also began in France, starting out in the 1990s as a health insurance card and later, when a federal law was passed in 2004, came to include an individual’s medical history. Germany introduced a similar health insurance card in the early 2000s, and last October added the medical history element. Soon, both these countries will require their citizens to have an H-SMART card to obtain health care and insurance.

It is expected that the European H-card will be developed to include a comprehensive health history in the next few years. And in the next decade or so, the card will likely be updated to include an individual’s genetic information as well. Thus, the H-SMART card eventually will contain a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Pushkar N. Kaul

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo